Literature DB >> 16631469

Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen.

Cláudia M Coutinho-Camillo1, Sibeli Salaorni, Alvaro S Sarkis, Maria A Nagai.   

Abstract

Androgens play an important role in growth and maintenance of prostate cells. The actions of androgens are mediated by the androgen receptor (AR), a transcription factor member of the super-family of nuclear hormone receptors. Androgen regulated genes (ARGs) are potential markers for early diagnosis and treatment of prostate cancer patients. In the present study, we used DDRT-PCR (differential display reverse transcriptase polymerase chain reaction) technique in order to investigate differentially expressed genes in the prostate cancer cell line LNCaP after treatment with dihydrotestosterone and bicalutamide for 6, 24, and 48 hours. Fifty-five differentially expressed fragments were isolated, cloned, and sequenced. Sequencing analysis of these fragments revealed 56 different transcripts that showed homology to transcription factors, cell cycle regulators, metabolic enzymes, and hypothetical proteins. Among the differentially expressed genes, SPA17 and DDEF2 were further validated using quantitative real time RT-PCR (qPCR) in a series of 25 prostate tumor samples. The DDEF2 gene is involved in adhesion and cell migration of monocytes, and the SPA17 gene might be involved in cellular signal transduction. The transcripts of both, SPA17 and DDEF2 genes, showed altered pattern of expression in the group of prostate tumors analyzed by qPCR. The differentially expressed genes identified in this study might provide new insights into the androgen signaling pathways in prostate cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631469     DOI: 10.1016/j.cancergencyto.2005.09.012

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.

Authors:  Tammy L Romanuik; Gang Wang; Olena Morozova; Allen Delaney; Marco A Marra; Marianne D Sadar
Journal:  BMC Med Genomics       Date:  2010-09-24       Impact factor: 3.063

2.  Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.

Authors:  Greg N Brooke; Simon C Gamble; Michael A Hough; Shajna Begum; D Alwyn Dart; Michael Odontiadis; Sue M Powell; Flavia M Fioretti; Rosie A Bryan; Jonathan Waxman; Robin Wait; Charlotte L Bevan
Journal:  Mol Cell Proteomics       Date:  2015-02-18       Impact factor: 5.911

3.  Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis.

Authors:  Masahiro Gotoh; Hitoshi Ichikawa; Eri Arai; Suenori Chiku; Hiromi Sakamoto; Hiroyuki Fujimoto; Masaki Hiramoto; Takao Nammo; Kazuki Yasuda; Teruhiko Yoshida; Yae Kanai
Journal:  Genes Chromosomes Cancer       Date:  2014-09-18       Impact factor: 5.006

4.  Integrative machine learning analysis of multiple gene expression profiles in cervical cancer.

Authors:  Mei Sze Tan; Siow-Wee Chang; Phaik Leng Cheah; Hwa Jen Yap
Journal:  PeerJ       Date:  2018-07-25       Impact factor: 2.984

5.  Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression.

Authors:  Ankur Bhowal; Subhadipa Majumder; Subarna Ghosh; Sanmitra Basu; Debrup Sen; Susanta Roychowdhury; Sanghamitra Sengupta; Urmi Chatterji
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

6.  MEF2‑activated long non‑coding RNA PCGEM1 promotes cell proliferation in hormone‑refractory prostate cancer through downregulation of miR‑148a.

Authors:  Shibao Zhang; Zongwu Li; Longyang Zhang; Zhonghua Xu
Journal:  Mol Med Rep       Date:  2018-05-04       Impact factor: 2.952

7.  Molecular cloning and analysis of the human PCAN1 (GDEP) promoter.

Authors:  Wenwen Liu; Weiwen Chen; Pengju Zhang; Chunxiao Yu; Feng Kong; Jingti Deng; Jianye Zhang; Anli Jiang
Journal:  Cell Mol Biol Lett       Date:  2007-04-28       Impact factor: 5.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.